PEDIATRICS Vol. 105 No. 3 March 2000, pp. 598-603
Childhood Encephalopathies and Myopathies: A Prospective Study in a Defined Population to Assess the Frequency of Mitochondrial Disorders
Received Oct 20, 1998; accepted Jun 22, 1999.
,,,
,, ¶,,
From the * Departments of Medical Biochemistry, Pediatrics,
§ Neurology, and Pathology, University of Oulu, Oulu, Finland;
and the ¶ Department of Pathology, Lapland Central Hospital, Rovaniemi,
Finland.
Objectives. To assess the frequency of mitochondrial abnormalities in muscle histology, defects in respiratory chain enzyme activities, and mutations in mitochondrial DNA (mtDNA) in children with unexplained psychomotor retardation in the population of Northern Finland.
Background. The frequency of mitochondrial diseases among patients with childhood encephalopathies and myopathies is not known. Frequencies are difficult to estimate because the clinical presentation of these disorders is variable.
Methods. A total of 116 consecutive patients with undefined encephalopathies and myopathies were enrolled during a 7-year period in a hospital serving as the only neurologic unit for a pediatric population of 97 609 and as the only tertiary level neurologic unit for a pediatric population of 48 873. Biochemical and morphologic investigations were performed on muscle biopsy material, including oximetric and spectrophotometric analyses of oxidative phosphorylation, histochemistry, electron microscopy, and molecular analysis of mtDNA.
Results. Ultrastructural changes in the mitochondria were the most common finding in the muscle biopsies (71%). Ragged-red fibers were found in 4 cases. An oxidative phosphorylation defect was found in 26 children (28%), complex I (n = 15) and complex IV (n = 13) defects being the most common. Fifteen percent of patients (n = 17/116) with unexplained encephalomyopathy or myopathy had a probable mitochondrial disease. Common pathogenic mutations were found in the mtDNA of only 1 patient (.9%).
Conclusions. The common known mutations in mtDNA are rarely causes of childhood encephalomyopathies, which is in contrast to the considerable frequency of the common MELAS mutation observed among adults in the same geographical area. Biochemically and morphologically verified mitochondrial disorders were nevertheless common among the children, making the analysis of a muscle biopsy very important for clinical diagnostic purposes. Key words: mitochondria, encephalomyopathies, children, mutation, respiratory chain, MELAS, mitochondrial DNA.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  M Pronicki, E Matyja, D Piekutowska-Abramczuk, T Szymanska-Debinska, A Karkucinska-Wieckowska, E Karczmarewicz, W Grajkowska, T Kmiec, E Popowska, and J Sykut-Cegielska Light and electron microscopy characteristics of the muscle of patients with SURF1 gene mutations associated with Leigh disease J. Clin. Pathol., April 1, 2008; 61(4): 460 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tardieu, F. Brunelle, C. Raybaud, W. Ball, B. Barret, B. Pautard, E. Lachassine, M.-J. Mayaux, and S. Blanche Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 695 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Scaglia, J. A. Towbin, W. J. Craigen, J. W. Belmont, E. O. Smith, S. R. Neish, S. M. Ware, J. V. Hunter, S. D. Fernbach, G. D. Vladutiu, et al. Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease Pediatrics, October 1, 2004; 114(4): 925 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Uusimaa, S. Finnila, A. M. Remes, H. Rantala, L. Vainionpaa, I. E. Hassinen, and K. Majamaa Molecular Epidemiology of Childhood Mitochondrial Encephalomyopathies in a Finnish Population: Sequence Analysis of Entire mtDNA of 17 Children Reveals Heteroplasmic Mutations in tRNAArg, tRNAGlu, and tRNALeu(UUR) Genes Pediatrics, August 1, 2004; 114(2): 443 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Uusimaa, S. Finnila, L. Vainionpaa, M. Karppa, R. Herva, H. Rantala, I. E. Hassinen, and K. Majamaa A Mutation in Mitochondrial DNA-Encoded Cytochrome c Oxidase II Gene in a Child With Alpers-Huttenlocher-Like Disease Pediatrics, March 1, 2003; 111(3): e262 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. I. Wolf and J. A.M. Smeitink Mitochondrial disorders: A proposal for consensus diagnostic criteria in infants and children Neurology, November 12, 2002; 59(9): 1402 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mandelbrot, A. Landreau-Mascaro, C. Rekacewicz, A. Berrebi, J. L. Benifla, M. Burgard, E. Lachassine, B. Barret, M.-L. Chaix, A. Bongain, et al. Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1 JAMA, April 25, 2001; 285(16): 2083 - 2093. [Abstract] [Full Text] [PDF]
|
|
